68Ga-FAPI PET/CT accurately monitors the dynamic changes of CAFs by TGF-β inhibition to assess tumor immunity and predict tumor response to ICBs in peritoneal metastatic CRC. This evidence concerns the gene TGFB1 and neoplasm.